A look at the history of Vertex Pharmaceuticals
Telaprevir is the company's latest drug, which was just approved by the Federal Drug Administration. It started clinical trials in 2001. The drug, combined with interferon and ribavirin therapy, could be used to treat hepatitis C. It will be competing with Merck & Co., who also have a drug to treat hepatitis C that has been approved. To prepare, Vertex has hired a marketing team.